Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16663
Country/Region: Burundi
Year: 2016
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $2,597,647 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $34,474
Care: TB/HIV (HVTB) $52,092
Care: Pediatric Care and Support (PDCS) $82,724
Health Systems Strengthening (OHSS) $130,194
Testing: HIV Testing and Counseling (HVCT) $688,329
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $619,897
Treatment: Adult Treatment (HTXS) $857,128
Treatment: Pediatric Treatment (PDTX) $132,809
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 110
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 110
GEND_GBV Number of people receiving post-GBV care 2017 110
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 2,106
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,701
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 118,352
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 32,849
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 155,008
HTS_TST Service Delivery Point (Facility): Index testing 2017 13,377
HTS_TST Service Delivery Point (Facility): Outpatient 2017 17,155
HTS_TST Service Delivery Point (Facility): PMTCT 2017 66,324
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,101
HTS_TST Service Delivery Point (Facility): VCT 2017 57,051
HTS_TST Sum of Aggregated Age/Sex <15 2017 3,807
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 151,201
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 155,008
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 17
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 16
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,944
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 836
LAB_PT CD4: Number of laboratories that perform this testing 2017 6
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 173
PMTCT_ART Already on ART at beginning of current pregnancy 2017 234
PMTCT_ART New on ART 2017 432
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 68,334
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 386
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 280
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 10
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 7
PMTCT_EID Sum of Infant Age disaggregates 2017 666
PMTCT_STAT By: Known positives at entry 2017 107
PMTCT_STAT By: Number of new positives identified 2017 440
PMTCT_STAT Number of new ANC and L&D clients 2017 71,930
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 68,334
PMTCT_STAT Sum of Positives Status disaggregates 2017 547
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 11
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 35
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 7
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 16
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 69
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 69
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,838
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,838
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 5,189
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,694
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 667
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 645
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 9,195
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 68
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 420
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 48
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 316
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 852
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 902
TX_CURR Aggregated Age/Sex: <15 Female 2017 667
TX_CURR Aggregated Age/Sex: <15 Male 2017 618
TX_CURR Aggregated Age/Sex: 15+ Female 2017 5,216
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,694
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 9,195
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,285
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 7,910
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 9,195
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 568
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 504
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,049
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 604
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,725
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,725
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 9,195
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 8,276
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 219
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 214
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 5,303
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 2,540
TX_PVLS Numerator: Indication: Routine 2017 8,276
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 333
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 310
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 5,717
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 2,835
TX_PVLS_den Denominator: Indication: Routine 2017 9,195
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 32
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 32
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 609
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 282
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 955
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,052
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 35
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 34
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 666
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 317